IGI Laboratories (IG) 9.07 $IG
IGI Laboratories To Present At 14th Annual Needham Healthcare Conference On April 14, 2015
PR Newswire - Mon Apr 13, 3:05PM CDT
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting tomorrow at the 14th Annual Needham Healthcare Conference. The Conference will take place on April 14-15, 2015, at The Westin Grand Central Hotel in New York, NY.
IG: 9.07 (+0.35)
IGI Laboratories, Inc. Announces First ANDA Submission Of 2015
PR Newswire - Thu Mar 26, 7:00AM CDT
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its first abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to twenty-three.
IG: 9.07 (+0.35)
IGI Laboratories, Inc. Appoints John Celentano to Board of Directors
PR Newswire - Mon Mar 23, 3:05PM CDT
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, today announced that it has appointed John Celentano to its Board of Directors. Mr. Celentano will also serve on the Company's Audit Committee.
IG: 9.07 (+0.35)
Why IGI, Laboratories (IG) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 7:36AM CDT
IGI, Laboratories (IG) has witnessed a significant price decline in the past four weeks, and it has lately seen significant negative earnings estimate revisions as well.
LCI: 66.45 (-0.28), IG: 9.07 (+0.35)
IGI Laboratories (IG) Downgraded From Buy to Hold
at The Street - Tue Mar 10, 11:00AM CDT
IGI Laboratories (IG) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
IG: 9.07 (+0.35)
Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories
PR Newswire - Tue Mar 10, 9:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZGNX: 1.63 (-0.02), PFE: 34.93 (+0.04), SNY: 51.59 (+0.03), IG: 9.07 (+0.35), NKTR: 10.90 (+0.16)
Insider Trading Alert - HYGS, STLY And IG Traded By Insiders
at The Street - Mon Mar 09, 1:00PM CDT
Stocks with insider trader activity include HYGS, STLY and IG
HYGS: 12.07 (+0.18), STLY: 3.08 (+0.01), IG: 9.07 (+0.35)
IGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015
PR Newswire - Mon Mar 09, 9:30AM CDT
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the 27th Annual ROTH Conference. The Conference will take place on March 8-11, 2015 at the Ritz-Carlton, Laguna Niguel, Dana Point, California.
IG: 9.07 (+0.35)
InsiderInsights.com Daily Round Up 3/6/15: BK, OAS, GPC, CAPL
InsiderInsights - at Seeking Alpha - Sat Mar 07, 11:01AM CST
OCR: 84.52 (+3.45), GPC: 93.02 (+0.57), BRCM: 46.18 (+2.20), QTWO: 20.06 (+0.04), CB: 99.30 (-0.44), AMRI: 18.48 (-0.19), LKFN: 40.28 (-0.05), PCLN: 1,212.90 (+18.64), HTWO: 9.70 (-0.11), GGP: 28.67 (-0.03), ARMK: 31.30 (+0.32), CAPL: 32.83 (+0.15), ETFC: 28.60 (+1.07), TWTR: 51.73 (+0.41), BLMN: 22.70 (unch), GRPN: 7.07 (-0.06), BK: 42.43 (+1.39), IG: 9.07 (+0.35), OAS: 16.47 (-0.36), ALCO: 48.09 (-1.52)
IGI, Laboratories (IG) Falls: Stock Goes Down 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 7:47AM CST
IGI, Laboratories saw a big move last session, as the company’s shares fell by nearly 12% which continued the downtrend for the company
LCI: 66.45 (-0.28), IG: 9.07 (+0.35)
IGI Laboratories' (IG) CEO Jason Grenfell Gardner on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Mar 02, 9:02PM CST
IG: 9.07 (+0.35)
IGI Laboratories EPS of $0.09
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 3:09PM CST
IG: 9.07 (+0.35)
IGI Laboratories Announces Fourth Quarter And Year End 2014 Results
PR Newswire - Mon Mar 02, 3:01PM CST
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced its financial results for the fourth quarter and year ended December 31, 2014.
IG: 9.07 (+0.35)
5 Stocks With Jaw-Dropping Growth Potential
George Budwell, The Motley Fool - Motley Fool - Sat Feb 28, 8:04AM CST
With the U.S. stock market hitting record highs of late and red hot sectors like health care sporting some jaw-dropping premiums, it's getting harder and harder to find stocks with compelling valuations. That being said, there are still a handful of...
VRX: 206.93 (-3.92), FLML: 15.84 (-0.33), PTX: 7.44 (-0.05), AZN: 73.35 (+0.65), TEVA: 63.01 (-1.15), GSK: 46.57 (-0.67), EGRX: 60.53 (+1.22), SNY: 51.59 (+0.03), ARDX: 12.51 (-0.01), IG: 9.07 (+0.35)
PTC Therapeutics (PTCT) Jumps: Stock Moves 9.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 8:11AM CST
PTC Therapeutics, Inc. (PTCT) was a big mover last session, as the company saw its shares rise roughly 10% on the day.
PTCT: 70.98 (unch), IG: 9.07 (+0.35)
Egalet (EGLT) Falls: Stock Goes Down 7.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:39AM CST
Shares of Egalet (EGLT) fell by nearly 8% on the day. This reverses the recent trend for EGLT as the stock is now up over 60% in the past one-month time frame. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future.
EGLT: 10.34 (-0.27), IG: 9.07 (+0.35)
Forget MannKind Corporation; Here Are 3 Better Biotech Stocks
Motley Fool Staff - Motley Fool - Sun Feb 22, 12:01PM CST
Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann's MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its...
VRX: 206.93 (-3.92), INSY: 62.10 (+0.76), AZN: 73.35 (+0.65), ACOR: 33.34 (-1.33), SNY: 51.59 (+0.03), MNKD: 4.90 (-0.09), IG: 9.07 (+0.35)
Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 7:51AM CST
Concert Pharmaceuticals, Inc. (CNCE) was a big mover last session, as the company saw its shares rise nearly 9% on the day.
IG: 9.07 (+0.35), CNCE: 14.83 (+0.26)
What's New in the Biotechnology Sector: Special Research on Vical,Asterias, Bacterin, Hemispherx BioPharma, and IGI Laboratories
PR Newswire - Thu Feb 19, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
VICL: 1.01 (-0.02), HEB: 0.25 (+0.01), AST: 13.61 (-0.11), IG: 9.07 (+0.35)
Ariad Pharmaceuticals (ARIA) Jumps: Stock Moves Up 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 17, 7:51AM CST
Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
ARIA: 9.23 (-0.04), IG: 9.07 (+0.35)
IGI Laboratories To Present At 14th Annual Needham Healthcare Conference On April 14, 2015
PR Newswire - Mon Apr 13, 3:05PM CDT
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting tomorrow at the 14th Annual Needham Healthcare Conference. The Conference will take place on April 14-15, 2015, at The Westin Grand Central Hotel in New York, NY.
IG: 9.07 (+0.35)
IGI Laboratories, Inc. Announces First ANDA Submission Of 2015
PR Newswire - Thu Mar 26, 7:00AM CDT
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its first abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to twenty-three.
IG: 9.07 (+0.35)
IGI Laboratories, Inc. Appoints John Celentano to Board of Directors
PR Newswire - Mon Mar 23, 3:05PM CDT
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, today announced that it has appointed John Celentano to its Board of Directors. Mr. Celentano will also serve on the Company's Audit Committee.
IG: 9.07 (+0.35)
Why IGI, Laboratories (IG) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 7:36AM CDT
IGI, Laboratories (IG) has witnessed a significant price decline in the past four weeks, and it has lately seen significant negative earnings estimate revisions as well.
LCI: 66.45 (-0.28), IG: 9.07 (+0.35)
IGI Laboratories (IG) Downgraded From Buy to Hold
at The Street - Tue Mar 10, 11:00AM CDT
IGI Laboratories (IG) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
IG: 9.07 (+0.35)
Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories
PR Newswire - Tue Mar 10, 9:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZGNX: 1.63 (-0.02), PFE: 34.93 (+0.04), SNY: 51.59 (+0.03), IG: 9.07 (+0.35), NKTR: 10.90 (+0.16)
Insider Trading Alert - HYGS, STLY And IG Traded By Insiders
at The Street - Mon Mar 09, 1:00PM CDT
Stocks with insider trader activity include HYGS, STLY and IG
HYGS: 12.07 (+0.18), STLY: 3.08 (+0.01), IG: 9.07 (+0.35)
IGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015
PR Newswire - Mon Mar 09, 9:30AM CDT
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the 27th Annual ROTH Conference. The Conference will take place on March 8-11, 2015 at the Ritz-Carlton, Laguna Niguel, Dana Point, California.
IG: 9.07 (+0.35)
InsiderInsights.com Daily Round Up 3/6/15: BK, OAS, GPC, CAPL
InsiderInsights - at Seeking Alpha - Sat Mar 07, 11:01AM CST
OCR: 84.52 (+3.45), GPC: 93.02 (+0.57), BRCM: 46.18 (+2.20), QTWO: 20.06 (+0.04), CB: 99.30 (-0.44), AMRI: 18.48 (-0.19), LKFN: 40.28 (-0.05), PCLN: 1,212.90 (+18.64), HTWO: 9.70 (-0.11), GGP: 28.67 (-0.03), ARMK: 31.30 (+0.32), CAPL: 32.83 (+0.15), ETFC: 28.60 (+1.07), TWTR: 51.73 (+0.41), BLMN: 22.70 (unch), GRPN: 7.07 (-0.06), BK: 42.43 (+1.39), IG: 9.07 (+0.35), OAS: 16.47 (-0.36), ALCO: 48.09 (-1.52)
IGI, Laboratories (IG) Falls: Stock Goes Down 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 7:47AM CST
IGI, Laboratories saw a big move last session, as the company’s shares fell by nearly 12% which continued the downtrend for the company
LCI: 66.45 (-0.28), IG: 9.07 (+0.35)
IGI Laboratories' (IG) CEO Jason Grenfell Gardner on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Mar 02, 9:02PM CST
IG: 9.07 (+0.35)
IGI Laboratories EPS of $0.09
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 3:09PM CST
IG: 9.07 (+0.35)
IGI Laboratories Announces Fourth Quarter And Year End 2014 Results
PR Newswire - Mon Mar 02, 3:01PM CST
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced its financial results for the fourth quarter and year ended December 31, 2014.
IG: 9.07 (+0.35)
5 Stocks With Jaw-Dropping Growth Potential
George Budwell, The Motley Fool - Motley Fool - Sat Feb 28, 8:04AM CST
With the U.S. stock market hitting record highs of late and red hot sectors like health care sporting some jaw-dropping premiums, it's getting harder and harder to find stocks with compelling valuations. That being said, there are still a handful of...
VRX: 206.93 (-3.92), FLML: 15.84 (-0.33), PTX: 7.44 (-0.05), AZN: 73.35 (+0.65), TEVA: 63.01 (-1.15), GSK: 46.57 (-0.67), EGRX: 60.53 (+1.22), SNY: 51.59 (+0.03), ARDX: 12.51 (-0.01), IG: 9.07 (+0.35)
PTC Therapeutics (PTCT) Jumps: Stock Moves 9.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 8:11AM CST
PTC Therapeutics, Inc. (PTCT) was a big mover last session, as the company saw its shares rise roughly 10% on the day.
PTCT: 70.98 (unch), IG: 9.07 (+0.35)
Egalet (EGLT) Falls: Stock Goes Down 7.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:39AM CST
Shares of Egalet (EGLT) fell by nearly 8% on the day. This reverses the recent trend for EGLT as the stock is now up over 60% in the past one-month time frame. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future.
EGLT: 10.34 (-0.27), IG: 9.07 (+0.35)
Forget MannKind Corporation; Here Are 3 Better Biotech Stocks
Motley Fool Staff - Motley Fool - Sun Feb 22, 12:01PM CST
Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann's MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its...
VRX: 206.93 (-3.92), INSY: 62.10 (+0.76), AZN: 73.35 (+0.65), ACOR: 33.34 (-1.33), SNY: 51.59 (+0.03), MNKD: 4.90 (-0.09), IG: 9.07 (+0.35)
Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 7:51AM CST
Concert Pharmaceuticals, Inc. (CNCE) was a big mover last session, as the company saw its shares rise nearly 9% on the day.
IG: 9.07 (+0.35), CNCE: 14.83 (+0.26)
What's New in the Biotechnology Sector: Special Research on Vical,Asterias, Bacterin, Hemispherx BioPharma, and IGI Laboratories
PR Newswire - Thu Feb 19, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
VICL: 1.01 (-0.02), HEB: 0.25 (+0.01), AST: 13.61 (-0.11), IG: 9.07 (+0.35)
Ariad Pharmaceuticals (ARIA) Jumps: Stock Moves Up 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 17, 7:51AM CST
Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
ARIA: 9.23 (-0.04), IG: 9.07 (+0.35)
